SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

diaDexus, Inc. – ‘8-K’ for 7/2/02

On:  Monday, 7/15/02, at 4:35pm ET   ·   For:  7/2/02   ·   Accession #:  1169232-2-143   ·   File #:  0-26483

Previous ‘8-K’:  ‘8-K’ on 5/13/02 for 4/24/02   ·   Next:  ‘8-K’ on 10/4/02 for 10/3/02   ·   Latest:  ‘8-K’ on 4/29/16 for 4/28/16

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/15/02  diaDexus, Inc.                    8-K:5,7     7/02/02    4:111K                                   Edgar Ease Svc Bureau/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4     12K 
 2: EX-99.1     Press Release Issued July 2, 2002                      2     10K 
 3: EX-99.2     Amended and Restated License and Supply Agreement     31    120K 
 4: EX-99.3     Press Release Issued July 8, 2002                      2     11K 


8-K   —   Current Report
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
2Item 5. Other Events
"Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
8-K1st Page of 4TOCTopPreviousNextBottomJust 1st
 

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2002 VAXGEN, INC. (Exact name of Registrant as Specified in its Charter) DELAWARE 0-26483 94-3236309 (State or other jurisdiction (Commission File (I.R.S. Employer of Identification Number) Number) incorporation or organization) 1000 MARINA BLVD., SUITE 200 BRISBANE, CALIFORNIA 94005 (Address of Principal Administrative Offices) Registrants Telephone Number, Including Area Code: (650) 624-1000
8-K2nd Page of 4TOC1stPreviousNextBottomJust 2nd
Item 5. Other Events. On July 2, 2002, VaxGen, Inc. (the "Company") announced that its May 1, 1996 License and Supply Agreement with Genentech, Inc. has been revised to give the Company greater flexibility in commercializing the Company's AIDS vaccine candidate. The press release is filed herewith as Exhibit 99.1 and incorporated herein by reference. The Amended and Restated License and Supply Agreement between VaxGen, Inc., and Genentech, Inc., entered into as of May 1, 2002 is filed herewith as Exhibit 99.2 and incorporated herein by reference. On July 8, 2002, the Company announced that Piers Whitehead has joined the Company as Vice President of Corporate and Business Development. The press release is filed herewith as Exhibit 99.3 and incorporated herein by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (c) Exhibits. EXHIBIT DESCRIPTION 99.1 Press Release issued July 2, 2002. 99.2 Amended and Restated License and Supply Agreement between VaxGen, Inc., and Genentech, Inc., entered into as of May 1, 2002. 99.3 Press Release issued July 8, 2002.
8-K3rd Page of 4TOC1stPreviousNextBottomJust 3rd
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VaxGen, Inc. (Registrant) Dated: July 15, 2002 By: /s/ Carter A. Lee --------------------------- Carter A. Lee Senior Vice President Finance & Administration
8-KLast Page of 4TOC1stPreviousNextBottomJust 4th
EXHIBIT INDEX EXHIBIT No. DESCRIPTION ----------- ----------- 99.1 Press Release issued July 2, 2002. 99.2 Amended and Restated License and Supply Agreement between VaxGen, Inc., and Genentech, Inc., entered into as of May 1, 2002. 99.3 Press Release issued July 8, 2002.

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘8-K’ Filing    Date First  Last      Other Filings
Filed on:7/15/023None on these Dates
7/8/0224
For Period End:7/2/0214
5/1/0224
5/1/962
 List all Filings 
Top
Filing Submission 0001169232-02-000143   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2020 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Sep. 26, 7:04:08.0am ET